ISIN | LU0329631377 |
---|---|
No. de valeur | 3535028 |
Bloomberg Global ID | VARMVI1 LX |
Nom de fond | Variopartner SICAV - MIV Global Medtech Fund I1 |
Prestataire de fonds |
MIV Global Medtech Fund
Feldeggstrasse 55 8008 Zürich Schweiz Téléphone: +41 44 253 64 11 E-Mail: info@mivam.ch |
Prestataire de fonds | MIV Global Medtech Fund |
Représentant en Suisse |
Vontobel Fonds Services AG Zürich Téléphone: +41 58 283 74 77 |
Distributeur(s) |
Vontobel Fonds Services AG Zürich Téléphone: +41 58 283 74 77 |
Classe d'actifs | Fonds en actions |
EFC Catégorie | Equity Health Care |
Catégorie de parts | Accumulation |
Pays d'origine | Luxembourg |
Conditions d'émission de parts | Pas de commission d'émission et/ou de taxes en faveur du fonds (l'émission a lieu à la valeur d'inventaire) |
Conditions de rachat de parts | Pas de commission de rachat et/ou de taxes en faveur du fonds (le rachat a lieu à la valeur d'inventaire) |
Stratégie d'investissement *** | This Sub-Fund aims to achieve maximum capital growth by means of investments in the sector of medical technology worldwide. In order to achieve this, and taking account of the principle of risk diversification, a minimum of two-thirds of the SubFund’s total assets are invested directly in equities, equity-like transferable securities, participation certificates, depositary receipts, such as American Depositary Receipts (ADRs), Global Depositary Receipts (GDRs) and European Depositary Receipts (EDRs) referring to such securities, etc. from issuers worldwide, mainly active in the sector of medical technology. Besides this, up to one third of the total assets of the Sub-Fund may be invested in participation securities from companies that are not or not principally active in the sector of medical technology. |
Particularités |
Prix actuel * | 2'616.70 CHF | 31.10.2024 |
---|---|---|
Prix précédent * | 2'660.32 CHF | 30.10.2024 |
Max 52 semaines * | 2'757.96 CHF | 27.03.2024 |
Min 52 semaines * | 2'139.12 CHF | 09.11.2023 |
NAV * | 2'616.70 CHF | 31.10.2024 |
Issue Price * | 2'616.70 CHF | 31.10.2024 |
Redemption Price * | 2'616.70 CHF | 31.10.2024 |
Closing Price * | ||
Prix minimal indicatif | ||
Actifs du fonds *** | 1'904'354'230 | |
Actifs de la classe *** | 529'418'916 | |
Trading Information SIX |
YTD Performance | +11.50% |
29.12.2023 - 31.10.2024
29.12.2023 31.10.2024 |
---|---|---|
1 mois | -0.65% |
30.09.2024 - 31.10.2024
30.09.2024 31.10.2024 |
3 mois | +3.32% |
31.07.2024 - 31.10.2024
31.07.2024 31.10.2024 |
6 mois | -0.11% |
30.04.2024 - 31.10.2024
30.04.2024 31.10.2024 |
1 an | +23.12% |
31.10.2023 - 31.10.2024
31.10.2023 31.10.2024 |
2 ans | +9.62% |
31.10.2022 - 31.10.2024
31.10.2022 31.10.2024 |
3 ans | -17.25% |
02.11.2021 - 31.10.2024
02.11.2021 31.10.2024 |
5 ans | +12.25% |
31.10.2019 - 31.10.2024
31.10.2019 31.10.2024 |
Quota de participation de capital en % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Part de la fortune du fonds en % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quota d'immobilier en % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | 0.7594 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date | 31.10.2024 |
Intuitive Surgical Inc | 9.92% | |
---|---|---|
Boston Scientific Corp | 9.81% | |
Stryker Corp | 9.72% | |
Abbott Laboratories | 9.71% | |
Medtronic PLC | 4.91% | |
Alcon Inc | 4.51% | |
Essilorluxottica | 4.21% | |
Becton Dickinson & Co | 4.03% | |
Hoya Corp | 3.93% | |
Edwards Lifesciences Corp | 3.44% | |
Dernière mise à jour des données | 30.09.2024 |
TER | 0.97% |
---|---|
Date TER | 28.06.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.90% |
Ongoing Charges *** | 0.97% |
SRRI ***
|
|
Date SRRI *** | 30.09.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |